what's better tirzepatide or retatrutide vs (2026): Differences in Weight Loss, Metabol – Revolution Health & Wellness Retatrutide vs Tirzepatide UK (2026)

The key is to be informed, monitor your symptoms, and stay in close contact with your healthcare provider

The study involved adults with type 2 diabetes and cardiovascular risk, who were randomized to receive tirzepatide (5 mg, 10 mg, or 15 mg) or insulin glargine (100 U/mL) over a treatment period of up to 104 weeks

[1] Patients with diabetes and pre-existing retinopathy should be monitored for worsening retinopathy during rapid improvement in glycemic control

Obesity is a known risk factor for the development of IIH, though the precise pathophysiology is unclear

Additional trials of SYNERGY-NASH (NCT04166773) will look into tirzepatide's effectiveness in nonalcoholic steatohepatitis (NASH) and its effect on those who are obese and have heart failure with maintained ejection fractions

Table 3.